Displaying 10 out of 60 results

  1. Pfizer

    Pfizer forecasts 2019 revenue, profit below Wall Street targets

  2. FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore

    Drugmaker GSK to split after striking Pfizer consumer health deal

    GlaxoSmithKline plans to split into two businesses - one for prescription drugs and vaccines, the other for over-the-counter products - after ...
  3. Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche buys US biotech Jecure in race for liver disease drugs

    Swiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat ...
  4. FILE PHOTO: Logo of U.S. pharmaceutical corporation Pfizer Inc. is seen in Zurich

    FDA approves Pfizer's treatment for rare blood cancer

    The U.S. Food and Drug Administration said on Wednesday it approved Pfizer Inc's treatment for a rare form of blood cancer in some adults.
  5. FILE PHOTO: A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca

    Pfizer loses blockbuster drug patent fight in UK Supreme Court

    Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case ...
  6. Pfizer

    Pfizer reports higher profits but trims sales forecast

  7. FILE PHOTO - The Pfizer logo is seen at their world headquarters in Manhattan, New York

    Pfizer's lung cancer drug get FDA nod

    Pfizer Inc said on Thursday its drug to treat a rare form of lung cancer got approval from the U.S. Food and Drug Administration.
  8. New Content Item

    Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer

  9. The Pfizer logo is seen at their world headquarters in New York

    Pfizer rare heart disease drug reduces risk of death by 30%: Study

  10. FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York

    Pfizer, Astellas revise two cancer drug trial protocols to speed up results

    Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug ...